CA2885619C - Topical ketoprofen composition - Google Patents

Topical ketoprofen composition Download PDF

Info

Publication number
CA2885619C
CA2885619C CA2885619A CA2885619A CA2885619C CA 2885619 C CA2885619 C CA 2885619C CA 2885619 A CA2885619 A CA 2885619A CA 2885619 A CA2885619 A CA 2885619A CA 2885619 C CA2885619 C CA 2885619C
Authority
CA
Canada
Prior art keywords
percent
ketoprofen
composition
carbopol
oxybenzone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2885619A
Other languages
English (en)
French (fr)
Other versions
CA2885619A1 (en
Inventor
Servet Buyuktimkin
Nadir Buyuktimkin
James L. Yeager
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Achelios Therapeutics Inc
Original Assignee
Achelios Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Achelios Therapeutics Inc filed Critical Achelios Therapeutics Inc
Publication of CA2885619A1 publication Critical patent/CA2885619A1/en
Application granted granted Critical
Publication of CA2885619C publication Critical patent/CA2885619C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
CA2885619A 2012-09-27 2013-09-24 Topical ketoprofen composition Active CA2885619C (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261706163P 2012-09-27 2012-09-27
US61/706,163 2012-09-27
US13/826,706 US8822537B2 (en) 2012-09-27 2013-03-14 Topical ketoprofen composition
US13/826,706 2013-03-14
PCT/US2013/061403 WO2014052313A1 (en) 2012-09-27 2013-09-24 Topical ketoprofen composition

Publications (2)

Publication Number Publication Date
CA2885619A1 CA2885619A1 (en) 2014-04-03
CA2885619C true CA2885619C (en) 2020-09-08

Family

ID=50339476

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2885619A Active CA2885619C (en) 2012-09-27 2013-09-24 Topical ketoprofen composition

Country Status (13)

Country Link
US (1) US8822537B2 (enExample)
EP (1) EP2900231B1 (enExample)
JP (1) JP6238991B2 (enExample)
KR (1) KR102184245B1 (enExample)
AU (1) AU2013323766B2 (enExample)
BR (1) BR112015006790B1 (enExample)
CA (1) CA2885619C (enExample)
ES (1) ES2902850T3 (enExample)
IL (1) IL237810B (enExample)
MX (1) MX373916B (enExample)
NZ (1) NZ706108A (enExample)
RU (1) RU2652345C2 (enExample)
WO (1) WO2014052313A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2995303A1 (en) 2009-07-10 2016-03-16 President and Fellows of Harvard College Permanently charged sodium and calcium channel blockers as anti-inflammatory agents
EP3226972A4 (en) * 2014-12-01 2018-08-08 Achelios Therapeutics, Inc. Methods and compositions for treating migraine and conditions associated with pain
WO2017024037A1 (en) 2015-08-03 2017-02-09 President And Fellows Of Harvard College Charged ion channel blockers and methods for use
US20180369174A1 (en) * 2015-12-16 2018-12-27 Achelios Therapeutics, Inc. Methods and compositions for treating peripheral neuropathy
JP2019510824A (ja) * 2016-03-31 2019-04-18 スマーテック・トピカル・インコーポレイテッドＳＭＡＲＴＥＣＨ ＴＯＰＩＣＡＬ，Ｉｎｃ． 送達システム
EA202091229A1 (ru) * 2017-11-30 2020-08-19 Ацьенде Кимике Рьюните Анджелини Франческо А.К.Р.А.Ф. С.П.А. Стабильная жидкая композиция кетопрофена, его солей и энантиомеров
EP3937945A4 (en) 2019-03-11 2023-01-04 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10786485B1 (en) 2019-03-11 2020-09-29 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
MA55307A (fr) 2019-03-11 2022-01-19 Nocion Therapeutics Inc Bloqueurs de canaux ioniques chargés et procédés d'utilisation
US10780083B1 (en) 2019-03-11 2020-09-22 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
BR112021017809A2 (pt) 2019-03-11 2021-11-23 Nocion Therapeutics Inc Bloqueadores de canais iônicos substituídos por éster e métodos para uso
CA3139559A1 (en) 2019-05-09 2020-11-12 Apkarian Technologies Llc Methods and compositions for treating pain
WO2021091585A1 (en) 2019-11-06 2021-05-14 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10933055B1 (en) 2019-11-06 2021-03-02 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US20220378729A1 (en) * 2019-11-06 2022-12-01 Smartech Topical, Inc. Topical formulations of cyclooxygenase inhibitors and their use
US12162851B2 (en) 2020-03-11 2024-12-10 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
JP7708777B2 (ja) 2020-03-11 2025-07-15 ノシオン セラピューティクス，インコーポレイテッド 荷電したイオンチャンネル遮断薬および使用方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60155111A (ja) * 1983-10-20 1985-08-15 Hisamitsu Pharmaceut Co Inc 安定なケトプロフェン含有外用経皮製剤
US5863527A (en) * 1996-09-04 1999-01-26 The Proctor & Gamble Company Personal care compositions
US6423697B1 (en) * 1999-01-14 2002-07-23 Mark Friedman Intraoral topical anti-inflammatory treatment for relief of migraine, tension-type headache, post-traumatic headache, facial pain, and cervical-muscle spasm
FR2804024B1 (fr) 2000-01-21 2002-09-13 Menarini France Nouvelles compositions pharmaceutiques a action anti- inflammatoire et leur procede de preparation
WO2005039531A1 (en) * 2003-10-10 2005-05-06 Antares Pharma Ipl Ag Transdermal pharmaceutical formulation for minimizing skin residues
CA2448065A1 (en) * 2001-05-30 2002-12-05 The Procter & Gamble Company Topical cosmetic composition comprising an alpha-beta-unsaturated ester as bonding agent
DE10141258B4 (de) * 2001-08-23 2004-09-23 Beiersdorf Ag Kosmetische und dermatologische Zubereitung und ihre Verwendung
US7235230B2 (en) * 2001-10-24 2007-06-26 Clariant Finance (Bvi) Limited Leave-on compositions for personal care
ITFI20030070A1 (it) * 2003-03-18 2004-09-19 Berlin Chemie Ag Formulazioni topiche stabilizzate contenenti ketoprofene
EP1488787A1 (en) * 2003-06-20 2004-12-22 Berlin-Chemie Ag Topical stabilized formulations containing ketoprofen
ES2590258T3 (es) * 2004-06-15 2016-11-21 Hisamitsu Pharmaceutical Co., Inc. Preparación antiinflamatoria y analgésica para uso externo
WO2006090833A1 (ja) * 2005-02-25 2006-08-31 Hisamitsu Pharmaceutical Co., Inc. 非ステロイド系消炎鎮痛剤を含有する外用経皮製剤
US8080237B2 (en) * 2005-09-15 2011-12-20 Benjamin Sredni Use of tellurium compounds for protection from ultra-violet radiation
US20090263340A1 (en) * 2006-04-18 2009-10-22 Dsm Ip Assets B.V. Cosmetic compositions
WO2009139817A2 (en) * 2008-04-15 2009-11-19 Sarcode Corporation Crystalline pharmaceutical and methods of preparation and use thereof
US8409600B2 (en) * 2009-01-23 2013-04-02 J&E Solutions, Llc Methods for prevention and/or treatment of capsular contracture
WO2011075688A1 (en) * 2009-12-18 2011-06-23 Exodos Life Sciences Limited Partnership Methods and compositions for treating and preventing trigeminal autonomic cephalgias, migraine, and vascular conditions

Also Published As

Publication number Publication date
BR112015006790A2 (pt) 2017-07-04
EP2900231B1 (en) 2021-11-03
AU2013323766B2 (en) 2017-08-17
EP2900231A1 (en) 2015-08-05
RU2015115723A (ru) 2016-11-20
RU2652345C2 (ru) 2018-04-25
JP2015531374A (ja) 2015-11-02
IL237810B (en) 2018-06-28
NZ706108A (en) 2018-03-23
CA2885619A1 (en) 2014-04-03
JP6238991B2 (ja) 2017-11-29
MX373916B (es) 2020-07-10
ES2902850T3 (es) 2022-03-30
AU2013323766A1 (en) 2015-04-09
US20140088195A1 (en) 2014-03-27
US8822537B2 (en) 2014-09-02
MX2015004006A (es) 2015-10-29
EP2900231A4 (en) 2016-03-02
KR20150074009A (ko) 2015-07-01
KR102184245B1 (ko) 2020-11-30
BR112015006790B1 (pt) 2022-05-31
WO2014052313A1 (en) 2014-04-03
HK1212898A1 (en) 2016-06-24

Similar Documents

Publication Publication Date Title
US8822537B2 (en) Topical ketoprofen composition
JP2015531374A5 (enExample)
US10085939B2 (en) Composition of dexibuprofen transdermal hydrogel
US10117829B2 (en) Diclofenac formulations
AU632655B2 (en) Method for percutaneous delivery of ibuprofen using hydroalcoholic gel
US5807568A (en) Enhanced delivery of topical compositions containing flurbiprofen
US20060211688A1 (en) Vehicle for topical delivery of anti-inflammatory compounds
US9220784B2 (en) Diclofenac topical formulation
EP0592569A1 (en) Composition and method for transdermal delivery of diclofenac
JP5052558B2 (ja) ゲル軟膏
US20060241175A1 (en) Vehicle for topical delivery of anti-inflammatory compounds
JP2003321347A (ja) ゲル軟膏
WO2005123136A1 (ja) 消炎鎮痛外用剤
JP4195178B2 (ja) 消炎鎮痛外用剤
JP3091285B2 (ja) 外用消炎鎮痛剤
Doppalapudi et al. Fenoldopam mesylate for treating psoriasis: A new indication for an old drug
KR101894891B1 (ko) 흡수가 증가된 덱시부프로펜 에멀젼 함유 겔 제형
HK1212898B (en) Topical ketoprofen composition
JP2004123632A (ja) 消炎鎮痛外用剤
JP2000247875A (ja) 外用消炎鎮痛剤
TR2021007476A2 (tr) Kas gevşeti̇ci̇ ajanlar i̇le kombi̇nasyon hali̇nde i̇ndometazi̇n i̇çeren topi̇kal bi̇leşi̇mler

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20180921

H11 Ip right ceased following rejected request for revival

Free format text: ST27 STATUS EVENT CODE: T-6-6-H10-H11-H101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: TIME LIMIT FOR REVERSAL EXPIRED

Effective date: 20250325